Biopolymer–clay nanocomposites for controlled drug delivery
Source abstract
Abstract
Polymer–clay nanocomposites have attracted great attention worldwide from both academic and industrial points of view. This review aims at reporting on very recent developments in types of polymer–clay nanocomposites, their constituents, synthetic routes, properties and their uses as carriers for drug delivery. This new family of composite materials frequently exhibits remarkable improvements of material properties when compared with the matrix polymers alone or conventional micro- and macrocomposites. Pharmaceutically, interesting improvements include increased mechanical and rheological properties, reduced drug permeability and water uptake and controlled release characteristics. On the basis of these properties, polymer–clay nanocomposites are extending their applicability to the design of new drug release dosage forms with highly specific technological and biopharmaceutical properties, such as swelling, film forming, bioadhesion, and cell uptake. Overall, there is an essential requirement directed towards a more comprehensive understanding of the supramolecular structure, drug loading and release mechanisms of these hybrid materials.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Polymer Nanocomposites and Properties · Clay minerals and soil interactions · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (91)
Show source-provided references
1. Chien Y. W.: in ‘Encyclopedia of pharmaceutical technology’, (ed.Swardbrick J., and Boylan J. C.), Vol. 3, 281-313; 1990, New York, Marcel Dekker.
2. Ding X., Alani A. W. G., and Robinson J. R.: in ‘Remington: the science and practice of pharmacy’, 21st edn, (ed.Troy D. B.), Chap. 47, 939-964; 2002, Philadelphia, Lippincott Williams & Wilkins.
3. Chien Y. W., and Lin S.: in: ‘Encyclopedia of pharmaceutical technology’, 2nd edn, (ed.Swardbrick J., and Boylan J. C.), Vol. 1, 811-833; 2002, Basel, Marcel Dekker.
4. Kibbe A. H. ‘Handbook of pharmaceutical excipients’, 3rd edn; 2000, Washington, American Pharmaceutical Association.
5. USP 31 and NF 26: ‘United States Pharmacopoeia 31 and National Formulary 26’; 2008, Rockville, US Pharmacopoeial Convention.
6. EP 6.0: ‘European Pharmacopoeia’, 6th edn; 2008, Strasbourg, Directorate for the Quality of Medicines of the Council of Europe.
7. 10.1016/j.clay.2006.06.01510.1016/j.clay.2006.06.015 ↗
8. 10.1016/j.ijpharm.2003.03.00110.1016/j.ijpharm.2003.03.001 ↗
9. Nair L. S. · Frog. Polym. Sci. · 2007 · 32 · 762
10. Coviello T., Matricardi P., Marianecci C., and Alhaique F.: J. Control. Rel., 2007, 119, (1 and 14),5–24.10.1016/j.jconrel.2007.01.004 ↗
11. 10.1016/S0927-796X(00)00012-710.1016/S0927-796X(00)00012-7 ↗
12. 10.1016/S1359-0286(02)00049-910.1016/S1359-0286(02)00049-9 ↗
13. Ray S. S. · Mater. Sc · 2005 · 962
14. 10.1002/adma.1996008010410.1002/adma.19960080104 ↗
15. 10.1016/S0032-3861(02)00318-X10.1016/S0032-3861(02)00318-X ↗
16. 10.1016/j.micromeso.2007.03.03310.1016/j.micromeso.2007.03.033 ↗
17. 10.1002/jps.260069071910.1002/jps.2600690719 ↗
18. 10.1016/S0169-1317(01)00043-610.1016/S0169-1317(01)00043-6 ↗
19. 10.1021/es000302110.1021/es0003021 ↗
20. 10.1016/j.jssc.2006.03.01910.1016/j.jssc.2006.03.019 ↗
21. Carja G., Niiyama H., Ciobanu G., and Aida T.: Mater. Sci. Eng. C, 2007, C27, (5-8),1129–1132.10.1016/j.msec.2006.07.017 ↗
22. 10.1016/j.clay.2006.06.01010.1016/j.clay.2006.06.010 ↗
23. 10.1016/j.clay.2007.07.00810.1016/j.clay.2007.07.008 ↗
24. 10.1016/j.ijpharm.2007.08.00810.1016/j.ijpharm.2007.08.008 ↗
25. 10.1016/j.addr.2007.08.04110.1016/j.addr.2007.08.041 ↗
26. Thombre A. G., and Cardinal J. R.: in ‘Encyclopedia of pharmaceutical technology’, (ed.Swardbrick J., and Boylan J. C.), Vol. 2, 61-88; 1990, New York, Marcel Dekker.
27. 10.1016/S0378-5173(02)00483-010.1016/S0378-5173(02)00483-0 ↗
28. 10.1016/S0928-0987(02)00127-610.1016/S0928-0987(02)00127-6 ↗
29. 10.1016/j.jconrel.2006.10.02310.1016/j.jconrel.2006.10.023 ↗
30. 10.1016/j.addr.2007.06.00310.1016/j.addr.2007.06.003 ↗
31. Lee K. Y. · Frog. Polym. Sci. · 2007 · 32 · 669
32. 10.1016/S0032-3861(03)00276-310.1016/S0032-3861(03)00276-3 ↗
33. 10.1016/S0168-3659(03)00133-010.1016/S0168-3659(03)00133-0 ↗
34. 10.1016/j.eurpolymj.2004.01.00510.1016/j.eurpolymj.2004.01.005 ↗
35. 10.1002/pola.2094110.1002/pola.20941 ↗
36. 10.1016/j.polymdegradstab.2006.01.00410.1016/j.polymdegradstab.2006.01.004 ↗
37. 10.1016/j.carbpol.2006.06.00410.1016/j.carbpol.2006.06.004 ↗
38. 10.1016/j.msea.2007.07.03110.1016/j.msea.2007.07.031 ↗
39. 10.1016/j.polymer.2007.06.06810.1016/j.polymer.2007.06.068 ↗
40. Chang M. Y., and Juang R. S.: Process Biochem. 2004, 39, 1087–1091.10.1016/S0032-9592(03)00221-8 ↗
41. Chang M. Y. · Eng · 2007 · 1 · 93
42. 10.1016/j.ijbiomac.2007.10.00410.1016/j.ijbiomac.2007.10.004 ↗
43. 10.1016/j.reactfunctpolym.2006.12.00210.1016/j.reactfunctpolym.2006.12.002 ↗
44. 10.1016/j.micromeso.2007.05.06410.1016/j.micromeso.2007.05.064 ↗
45. Blumstein A. · J. Polym. Sci. A · 1965 · 3 · 2665
46. 10.1002/pola.1995.08033070710.1002/pola.1995.080330707 ↗
47. 10.1557/JMR.1993.117410.1557/JMR.1993.1174 ↗
48. 10.1021/cm00024a04810.1021/cm00024a048 ↗
49. 10.1021/cm00036a00410.1021/cm00036a004 ↗
50. 10.1016/j.carbpol.2005.11.00310.1016/j.carbpol.2005.11.003 ↗
51. Odidi I., and Odidi A.: Int. Pat. Appl., 2007, WO 2007131357, 84.
52. Greenblatt D., Hughes L., and Whitman D. W.: Eur. Pat. Appl, 2004, EP1470823, 13.
53. Lukham P. F. · Colloid Interface Sc · 1999 · 4310.1016/S0001-8686(99)00005-6 ↗
54. 10.1016/S0927-7757(99)00032-110.1016/S0927-7757(99)00032-1 ↗
55. 10.1016/S0169-1317(99)00040-X10.1016/S0169-1317(99)00040-X ↗
56. 10.1016/j.jconrel.2005.03.03110.1016/j.jconrel.2005.03.031 ↗
57. 10.1016/S0169-1317(99)00041-110.1016/S0169-1317(99)00041-1 ↗
58. 10.1016/S0169-7722(00)00154-610.1016/S0169-7722(00)00154-6 ↗
59. 10.1016/j.clay.2006.11.00110.1016/j.clay.2006.11.001 ↗
60. Nagasaki Y., Takahashi T., Kataoka K., and Yamada Y.: Int. Pat. Appl, WO 2005005548, 2005, 38.
61. Lin C. · Drug Del. Re
62. Peppas N. A. · Drug Del. Re · 1993 · 1
63. Messersmith P. B., and Znidarsich F.: Proc. Materials Research Society Symposium on ‘Nanophase and nanocomposite materials’, Material Research Society, Dec 1996, Pittsburgh, USA, 1997, 507.
64. 10.1016/S0966-7822(97)00014-210.1016/S0966-7822(97)00014-2 ↗
65. 10.1002/app.1262410.1002/app.12624 ↗
66. 10.1002/app.2073010.1002/app.20730 ↗
67. 10.1016/S0168-3659(03)00133-010.1016/S0168-3659(03)00133-0 ↗
68. 10.1016/j.jconrel.2005.07.00310.1016/j.jconrel.2005.07.003 ↗
69. 10.1016/j.ijpharm.2006.09.04610.1016/j.ijpharm.2006.09.046 ↗
70. 10.1016/j.ijpharm.2007.05.05810.1016/j.ijpharm.2007.05.058 ↗
71. 10.1016/j.carbpol.2006.08.02510.1016/j.carbpol.2006.08.025 ↗
72. 10.1016/j.clay.2006.07.00610.1016/j.clay.2006.07.006 ↗
73. 10.1211/002235705579510.1211/0022357055795 ↗
74. 10.1016/j.ijpharm.2007.09.03810.1016/j.ijpharm.2007.09.038 ↗
75. 10.1208/pt080307210.1208/pt0803072 ↗
76. 10.1016/0169-409X(93)90031-X10.1016/0169-409X(93)90031-X ↗
77. 10.1016/0169-409X(93)90011-R10.1016/0169-409X(93)90011-R ↗
78. 10.1016/0169-409X(94)90026-410.1016/0169-409X(94)90026-4 ↗
79. 10.1016/j.addr.2005.07.00310.1016/j.addr.2005.07.003 ↗
80. 10.1016/j.jconrel.2006.04.01210.1016/j.jconrel.2006.04.012 ↗
81. 10.1002/app.1349910.1002/app.13499 ↗
82. 10.1016/j.biomaterials.2005.03.02110.1016/j.biomaterials.2005.03.021 ↗
83. 10.1128/AEM.51.1.65-73.198610.1128/AEM.51.1.65-73.1986 ↗
84. 10.1016/j.ijpharm.2004.12.00610.1016/j.ijpharm.2004.12.006 ↗
85. 10.1016/j.compscitech.2007.05.00810.1016/j.compscitech.2007.05.008 ↗
86. 10.1080/1060132670805374510.1080/10601326708053745 ↗
87. 10.1016/S0376-7388(00)80877-710.1016/S0376-7388(00)80877-7 ↗
88. 10.1063/1.47782910.1063/1.477829 ↗
89. Beall G. W.: in ‘Polymer-clay nanocomposites’, (ed.Pinnavaia T. J., and Beall G. W.), 267-279; 2000, Chichester, John Wiley and Sons.
90. 10.1021/ma010780b10.1021/ma010780b ↗
91. 10.1021/ma021377n10.1021/ma021377n ↗